Search

everythinglearnresearchcommunity

for

Search:↓

The lotion CG428 did not show effectiveness in treating permanent hair loss in breast cancer survivors.

After chemotherapy for early breast cancer, 33.4% of patients had long-term significant hair loss, with some hair regrowth over time, but treatments for hair loss were largely ineffective.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

Pegylated liposomal doxorubicin is as effective as conventional doxorubicin but causes fewer heart problems and side effects.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Nanoparticle delivery can reduce side effects of the cancer drug doxorubicin.

DNA nanostructures could be a cost-effective way to deliver cancer drugs with fewer side effects.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

MK-5108 is safe and shows potential against tumors, especially alone.

Eliminating senescent cells can prevent and reverse chemotherapy-induced peripheral neuropathy.

The nanocomposite effectively targets lung cancer cells without harming normal cells.

Radiotherapy affects mitochondrial-related genes in metastatic breast cancer cells.

Melatonin may help prevent hair loss caused by the chemotherapy drug paclitaxel.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

The combination treatment showed a higher response rate but no significant survival benefits.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Tofacitinib might be used to treat hair loss.

Doxorubicin can block blood vessels from hair follicles, reducing skin tumor growth.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Etoposide makes radiation therapy more effective against tumors without major side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.